Clinical Recovery Should Be Considered as an Outcome Measure in Clinical Trials Including Patients With New-Onset Hypoxemia
- PMID: 37945201
- DOI: 10.1016/j.chest.2023.07.015
Clinical Recovery Should Be Considered as an Outcome Measure in Clinical Trials Including Patients With New-Onset Hypoxemia
Conflict of interest statement
Financial/Nonfinancial Disclosures The authors have reported to CHEST the following: A. C. declares a patent #102019000020532 not discussed in the present study and no conflict of interests related to this work. C. C. declares a patent pending #102023000013077 not discussed in the present study and no conflict of interests related to this work.
Comment in
-
Response.Chest. 2023 Nov;164(5):e158-e159. doi: 10.1016/j.chest.2023.07.016. Epub 2023 Nov 7. Chest. 2023. PMID: 37945202 No abstract available.
Comment on
-
Oxygen-Free Days as an Outcome Measure in Clinical Trials of Therapies for COVID-19 and Other Causes of New-Onset Hypoxemia.Chest. 2022 Oct;162(4):804-814. doi: 10.1016/j.chest.2022.04.145. Epub 2022 Apr 30. Chest. 2022. PMID: 35504307 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources